摘要对介入封堵治疗室间隔缺损的应用情况以及适应症。To review the application of transcatheter closure of ventricular septal defects, as well as to discuss the related indications and complications.
1[1]Fabrega SJ, Rodes J, Piechaud J, Albert BD, Casaldaliga FJ, Goncalves A, Girona CJ. Percutaneous closure of a mid-muscular residual ventricular septal defect using the Amplatzer (TM) device [J]. An Esp Pediatr, 2002;57(1):66-69.
2[2]Chessa M, Carminati M, Cao QL, Butera G, Giusti S, Bini RM, Hijazi ZM. Transcatheter closure of congenital and acquired muscular ventricular septal defects using the Amplatzer device [J]. J Invasive Cardiol, 2002;14(6):322-327.
2THANOPOUI.OS B D, TSAOUSIS G S, KARANASIOS E. Transcatheter closure of perimembranous ventricular septal defects with the Amplatzer asmmetric ventricular septal defect occluder: preliminary experience in children [J].Heart, 2003,89 : 918-922.
3HUAZI Z M, HAKIM F, HAWELEH A A, et al. Catheter closure of perimembranous ventricular septal defects using the new Amplatzer membranous VSD occluder:initial clinical experience[J].Catheter Cardiovasc Interv, 2002,56:508-515.
